Dr. Nabors is an accomplished biopharmaceutical executive with 25 years of industry experience, and a track record for achieving results at small, medium, and large biopharma companies, with emphasis on vaccines and antibody products. He has broad experience in biopharmaceutical product development from pre-clinical stages through Phase 3 for pediatric, adult, travelers, and biodefense markets. Dr. Nabors has served in the capacity of a strategic leader with a focus on managing projects to timeline and budget to facilitate meeting business goals. His experience in advanced development of biological products has led to a great deal of interaction with the FDA to move products forward into clinical development. He has a demonstrated ability to lead Research and Development functions through effective technical management and winning government grants and contracts. Dr. Nabors has prior work experience at DynPort Vaccine Company, The National Biological Threat Characterization Center, Emergent BioSolutions, Antex Biologics, and Sanofi Pasteur. Dr. Nabors earned a BA in Biology from Wake Forest University and a Ph.D. in Immunology from the University of Georgia.